EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access

Impact of Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors on Nocturnal Polyuria: A Cross-Sectional Study

Seisuke Sato, Takafumi Yoshimura, Kurumi Komori, Takanobu Saheki, Toshihiro Kobayashi, Kensaku Fukunaga, Hitomi Imachi, Koji Murao

Cureus · 08.03.2025

DOI: 10.7759/cureus.80263 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Cureus, erschienen am 08.03.2025. Verfasst von Seisuke Sato und 7 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, Sato Internal Medicine Clinic, Takamatsu, JPN. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

diabetesnocturianocturnal polyuriasglt2-inhibitorssodium-glucose cotransporter-2 (sglt-2) inhibitorstofogliflozin

Autor:innen und Institutionen

  • Internal Medicine, Sato Internal Medicine Clinic, Takamatsu, JPN.
  • Endocrinology and Metabolism, Kagawa University, Miki-chō, JPN.

Zitieren

APA

Sato, S., Yoshimura, T., Komori, K., Saheki, T., Kobayashi, T., Fukunaga, K., Imachi, H., & Murao, K. (2025). Impact of Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors on Nocturnal Polyuria: A Cross-Sectional Study. Cureus. https://doi.org/10.7759/cureus.80263

Vancouver

Sato S, Yoshimura T, Komori K, Saheki T, Kobayashi T, Fukunaga K, et al. Impact of Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors on Nocturnal Polyuria: A Cross-Sectional Study. Cureus. 2025. doi:10.7759/cureus.80263

BibTeX
@article{Sato2025,
  author = {Sato, Seisuke and Yoshimura, Takafumi and Komori, Kurumi and Saheki, Takanobu and Kobayashi, Toshihiro and Fukunaga, Kensaku and Imachi, Hitomi and Murao, Koji},
  title = {Impact of Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors on Nocturnal Polyuria: A Cross-Sectional Study},
  journal = {Cureus},
  year = {2025},
  doi = {10.7759/cureus.80263}
}
Kostenlos starten →